Right now, Medicare plans are allowed to cover weight-loss drugs for "nonobesity uses," like reducing the risk of heart attacks
IV repletion is used in clinical practice as part of protocols for NAFLD, NASH, alcoholic liver disease, viral hepatitis B and C, heavy metal and environmental toxin exposure, mold toxicity protocols, and post-acetaminophen toxicity recovery
Most of retatrutide's effects come from reducing fat mass, likely because it helps people eat less food for longer periods compared to similar medications
In our study, concentration of protein and albumin were not affected by different levels of L-carnitine and Lys-Met
However, BPC 157 is a therapeutic agent not approved by the FDA, which cites risk of immunogenicity, peptide-related impurities, and limited safety-related information as reasons for banning BPC-157